# OLMA (Olema Pharmaceuticals, Inc.) - SEC EDGAR Financial Statements

> Olema Pharmaceuticals, Inc. reported $441.1M in total assets and a net loss of $235.9M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/OLMA
- Markdown: https://convexityos.com/fundamentals/OLMA.md
- SEC CIK: 0001750284
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:34 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001750284&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$252.8M | Operating profit |
| Net Income | FY 2025 | -$235.9M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$2.33 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $413.8M | Total debt: $356K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $157.7M | $124.5M | $86.14M | $82.27M | $51.10M | $13.70M | $3.92M |
| Total Operating Expenses | $178.7M | $142.3M | $105.0M | $107.0M | $71.49M | $21.53M | $4.32M |
| **Operating Income** | -$178.7M | -$142.3M | -$105.0M | -$107.0M | -$71.49M | -$21.53M | -$4.32M |
| **EBITDA** | -$178.2M | -$141.9M | -$104.6M | -$106.6M | -$71.33M | -$21.52M | -$4.31M |
| Interest Income | $16.22M | $12.68M | $8.32M | $2.23M | $442K | $60K | $7.0K |
| Interest Expense | -- | -- | -- | -- | -- | $653K | -- |
| Income Before Tax | -$162.4M | -$129.5M | -- | -- | -- | -- | -- |
| Income Tax Expense | $3.0K | $2.0K | $2.0K | $1.0K | -- | -- | -- |
| **Net Income** | -$162.5M | -$129.5M | -$96.66M | -$104.8M | -$71.10M | -$22.12M | -$4.32M |
| Basic EPS | -$1.87 | -$2.20 | -$2.14 | -$2.62 | -$1.80 | -$3.42 | -$1.66 |
| **Diluted EPS** | -$1.87 | -$2.20 | -$2.14 | -$2.62 | -$1.80 | -$3.42 | -$1.66 |
| Basic Shares Outstanding | 87.0M | 58.7M | 45.2M | 40.0M | 39.5M | 7.0M | 2.6M |
| Diluted Shares Outstanding | 87.0M | 58.7M | 45.2M | 40.0M | 39.5M | 7.0M | 2.6M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $67.60M | $57.78M | $49.23M | $43.22M | $39.95M | $43.90M | $30.62M | $32.30M |
| Total Operating Expenses | $77.53M | $67.18M | $57.99M | $50.08M | $45.88M | $47.86M | $34.87M | $36.77M |
| **Operating Income** | -$77.53M | -$67.18M | -$57.99M | -$50.08M | -$45.88M | -$47.86M | -$34.87M | -$36.77M |
| **EBITDA** | -$77.43M | -$67.08M | -$57.87M | -$49.90M | -$45.83M | -$47.73M | -$34.74M | -$36.65M |
| Interest Income | $4.05M | $4.51M | $4.78M | $4.01M | $3.65M | $4.04M | $4.52M | $3.29M |
| **Net Income** | -$73.60M | -$63.20M | -$53.09M | -$46.06M | -$42.22M | -$43.78M | -$30.39M | -$33.57M |
| Basic EPS | -$0.73 | -$0.61 | -$0.52 | -- | -$0.49 | -$0.51 | -$0.36 | -- |
| **Diluted EPS** | -$0.73 | -$0.61 | -$0.52 | -- | -$0.49 | -$0.51 | -$0.36 | -- |
| Basic Shares Outstanding | 101.1M | 104.5M | 102.8M | -- | 85.7M | 85.5M | 85.4M | -- |
| Diluted Shares Outstanding | 101.1M | 104.5M | 102.8M | -- | 85.7M | 85.5M | 85.4M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $48.30M | $139.5M | $68.54M | $23.70M | $13.81M | $338.5M |
| Short-Term Investments | $457.1M | $294.6M | $193.3M | $180.7M | $273.4M | -- |
| **Cash & Short-Term Investments** | $505.4M | $434.1M | $261.8M | $204.4M | $287.3M | $338.5M |
| **Total Current Assets** | $515.5M | $438.5M | $266.5M | $208.9M | $290.7M | $342.1M |
| Property, Plant & Equipment, Net | $274K | $746K | $968K | $1.48M | $1.47M | $75K |
| Other Non-Current Assets | -- | $15K | -- | $2.77M | $540K | $510K |
| **Total Non-Current Assets** | $17.98M | $12.51M | $10.43M | $6.75M | $5.26M | $585K |
| **Total Assets** | $533.4M | $451.0M | $276.9M | $215.6M | $295.9M | $342.7M |
| Accounts Payable | $9.25M | $4.46M | $2.70M | $374K | $23K | $719K |
| Other Current Liabilities | $41.42M | $36.13M | $17.93M | $15.16M | $8.06M | $3.87M |
| **Total Current Liabilities** | $51.80M | $41.76M | $21.62M | $16.55M | $9.02M | $4.58M |
| **Total Non-Current Liabilities** | $3.07M | $257K | $1.43M | $1.55M | $2.36M | $0 |
| **Total Liabilities** | $54.87M | $42.02M | $23.05M | $18.10M | $11.38M | $4.58M |
| **Total Debt (incl. Leases)** | $1.19M | $1.43M | $2.42M | $2.56M | $3.29M | -- |
| Common Stock | $8.0K | $7.0K | $4.0K | $3.0K | $3.0K | $3.0K |
| Retained Earnings | -$597.6M | -$435.1M | -$305.6M | -$209.0M | -$104.2M | -$33.09M |
| Accumulated Other Comp. Income | $621K | $143K | $347K | -$1.81M | -$149K | -- |
| **Total Stockholders' Equity** | $478.6M | $409.0M | $253.9M | $197.5M | $284.6M | $338.1M |
| Total Equity | $478.6M | $409.0M | $253.9M | $197.5M | $284.6M | $338.1M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $47.52M | $48.60M | $52.55M | $48.30M | $35.26M | $52.47M | $50.64M | $139.5M |
| Short-Term Investments | $366.2M | $412.5M | $452.8M | $457.1M | $293.7M | $309.4M | $342.1M | $294.6M |
| **Cash & Short-Term Investments** | $413.8M | $461.1M | $505.3M | $505.4M | $329.0M | $361.9M | $392.7M | $434.1M |
| **Total Current Assets** | $423.4M | $469.9M | $513.2M | $515.5M | $334.3M | $367.7M | $396.7M | $438.5M |
| Property, Plant & Equipment, Net | $1.65M | $382K | $356K | $274K | $486K | $560K | $653K | $746K |
| Other Non-Current Assets | -- | -- | -- | -- | -- | $15K | $14K | $15K |
| **Total Non-Current Assets** | $17.64M | $16.70M | $17.42M | $17.98M | $18.12M | $14.28M | $12.98M | $12.51M |
| **Total Assets** | $441.1M | $486.6M | $530.6M | $533.4M | $352.5M | $382.0M | $409.6M | $451.0M |
| Accounts Payable | $1.21M | $1.67M | $3.72M | $9.25M | $3.47M | $934K | $151K | $4.46M |
| Other Current Liabilities | $67.67M | $50.69M | $42.49M | $41.42M | $37.01M | $31.08M | $24.89M | $36.13M |
| **Total Current Liabilities** | $69.23M | $53.01M | $47.17M | $51.80M | $41.66M | $33.16M | $26.06M | $41.76M |
| **Total Non-Current Liabilities** | $3.00M | $3.00M | $3.00M | $3.07M | $3.31M | $3.60M | $123K | $257K |
| **Total Liabilities** | $72.23M | $56.01M | $50.17M | $54.87M | $44.97M | $36.77M | $26.19M | $42.02M |
| **Total Debt (incl. Leases)** | $356K | $660K | $956K | $1.19M | $1.48M | $1.75M | $1.15M | $1.43M |
| Common Stock | $8.0K | $8.0K | $8.0K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K |
| Retained Earnings | -$787.4M | -$713.8M | -$650.6M | -$597.6M | -$551.5M | -$509.3M | -$465.5M | -$435.1M |
| Accumulated Other Comp. Income | -$1.59M | -$947K | -$460K | $621K | $526K | $314K | $420K | $143K |
| **Total Stockholders' Equity** | $368.8M | $430.6M | $480.5M | $478.6M | $307.5M | $345.2M | $383.5M | $409.0M |
| Total Equity | $368.8M | $430.6M | $480.5M | $478.6M | $307.5M | $345.2M | $383.5M | $409.0M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$162.5M | -$129.5M | -$96.66M | -$104.8M | -$71.10M | -$22.12M | -$4.32M |
| Depreciation & Amortization | $490K | $393K | $377K | $357K | $163K | $11K | $9.0K |
| Stock-Based Compensation | $17.59M | $22.58M | $17.26M | $18.83M | $15.91M | $3.11M | -- |
| Change in Payables | $4.60M | $2.51M | $2.32M | $351K | -$683K | -$220K | $810K |
| **Operating Cash Flow** | -$146.7M | -$104.4M | -$83.73M | -$82.06M | -$50.69M | -$19.87M | -$3.08M |
| Capital Expenditure | -- | -$159K | -- | -$363K | -$1.57M | -$56K | -- |
| **Free Cash Flow** | -- | -$104.5M | -- | -$82.43M | -$52.27M | -$19.92M | -- |
| Purchases of Investments | -$500.7M | -$395.0M | -$255.6M | -$213.7M | -$487.0M | -- | -- |
| **Investing Cash Flow** | -$155.8M | -$93.53M | -$4.85M | $91.48M | -$275.4M | -$56K | -- |
| **Financing Cash Flow** | $211.3M | $268.8M | $133.4M | $476K | $1.39M | $358.4M | -- |
| **Net Change in Cash** | -$91.18M | $70.94M | $44.84M | $9.89M | -$324.7M | $338.5M | -$3.08M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$73.60M | -$63.20M | -$53.09M | -$46.06M | -$42.22M | -$43.78M | -$30.39M | -$33.57M |
| Depreciation & Amortization | $94K | $102K | $119K | $187K | $43K | $132K | $128K | $116K |
| Stock-Based Compensation | $12.08M | $12.90M | $10.15M | $4.27M | $4.25M | $4.69M | $4.38M | $6.32M |
| Change in Payables | -$458K | -$1.91M | -$5.68M | $5.77M | $2.39M | $743K | -$4.31M | $2.52M |
| **Operating Cash Flow** | -$47.11M | -$45.90M | -$45.99M | -$38.33M | -$34.53M | -$29.88M | -$43.98M | -$26.28M |
| Capital Expenditure | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Free Cash Flow** | -- | -- | -- | -- | -- | -- | -- | -$26.28M |
| Purchases of Investments | -$50.77M | -$48.24M | -$69.94M | -$253.4M | -$71.65M | -$32.86M | -$142.9M | -$189.2M |
| **Investing Cash Flow** | $45.60M | $40.84M | $4.53M | -$162.2M | $17.27M | $34.23M | -$45.08M | -$114.4M |
| **Financing Cash Flow** | $434K | $1.11M | $45.70M | $213.6M | $41K | -$2.52M | $222K | $244.3M |
| **Net Change in Cash** | -$1.08M | -$3.95M | $4.25M | $13.04M | -$17.21M | $1.83M | -$88.84M | $103.6M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -33.9% | -31.7% | -38.1% | -53.0% | -25.0% | -6.5% | -- |
| Return on Assets (ROA) | -30.5% | -28.7% | -34.9% | -48.6% | -24.0% | -6.5% | -- |
| Current Ratio | 9.95x | 10.50x | 12.33x | 12.62x | 32.23x | 74.62x | -- |
| Quick Ratio | 9.76x | 10.40x | 12.11x | 12.35x | 31.85x | 73.84x | -- |
| Debt to Equity | 0.00x | 0.00x | 0.01x | 0.01x | 0.01x | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -64.0% | -47.5% | -38.5% | -33.9% | -48.8% | -41.2% | -33.6% | -31.7% |
| Return on Assets (ROA) | -53.5% | -42.0% | -34.9% | -30.5% | -42.5% | -37.2% | -31.5% | -28.7% |
| Current Ratio | 6.12x | 8.86x | 10.88x | 9.95x | 8.03x | 11.09x | 15.22x | 10.50x |
| Quick Ratio | 5.98x | 8.70x | 10.71x | 9.76x | 7.90x | 10.91x | 15.07x | 10.40x |
| Debt to Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.00x | 0.00x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
